Navigation Links
InsuranceSpecialists.com Looks at the Candidates and Health Reform
Date:7/9/2008

ists writers break down the major positions held by John McCain, Hillary Clinton, and Barak Obama in short, concise chunks that are easily digestible and understood. Issues of tax ramifications, compulsory versus voluntary participation, and total cost are addressed.

"Sure Clinton is technically out of the race now," said Davidson, "but she's still tremendously influential and will be more so if a Democrat takes the White House. We're not interested in predicting who will win the race, we just want to help our readers understand how all the major political players see this issue in the long term."

Davidson added that neither he nor his staff ever lose sight of the InsuranceSpecialists mission statement: "Our job at Insurancespecialists.com is to give you the information you need to decide which health insurance coverage is right for you and your loved ones. Through insurance statistics, policy information, and insurance rate quotes, we hope to make the burden of these decisions a little easier. Taking the time to read our insurance descriptions and classifications may help you sort out which policies will be most advantageous, and most timely to obtain."

By focusing on current affairs as well as supplying educational articles and regular industry news updates, InsuranceSpecialists.com not only helps consumers find affordable insurance, but educates them in the process. Site content is continually updated and the editors welcome and invite your questions, comments, and ideas. Send email to: editor @ carinsurancelist.com.

Corporate Summary

InsuranceSpecialists.com, based in San Jose, California, offers in-depth information an
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. IMPACT initiative looks to improve patient participation in clinical trials
2. Test for lung cancer looks for discomforting quiet among protective genes
3. Study looks at mitochondrial variation in sperm traits and sperm competitive ability
4. Experts Agree. Ohios Technology Investment Future Looks Bright
5. New Book Looks at Clinical Research from the Patients Point of View
6. Study looks at off-label use of biliary stents
7. Granholm Looks To Make Big Bucks for Personal Injury Lawyers, Says Michigan Chamber of Commerce
8. Fi-Med Management, Inc. Acquires California and Utah-based Mediplete, Looks Ahead to Another Year of Growth
9. Study looks at new bladder cancer therapy for patients unresponsive to standard treatment
10. Surgery looks at inventions and innovations by surgeons
11. Iowa State University researcher looks to use nanoparticles for food safety
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 1Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 3Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 4Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 5Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 6Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 7Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 8Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 9Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 10Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 11ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 1ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 2ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 3Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 1Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 2